2015
DOI: 10.1016/j.semarthrit.2014.11.003
|View full text |Cite
|
Sign up to set email alerts
|

Safety of disease-modifying antirheumatic drugs and biologic agents for rheumatoid arthritis patients in real-life conditions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
14
0
2

Year Published

2015
2015
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(21 citation statements)
references
References 40 publications
5
14
0
2
Order By: Relevance
“…These combination therapies have been shown to be superior to MTX monotherapy in reducing disease symptoms more rapidly and preventing radiographic damage in more patients . However, some combination therapies may also lead to more adverse reactions than MTX monotherapy . Specific recommendations regarding the MTX dosage when used in combination with other (types of) medication do not exist.…”
Section: Introductionmentioning
confidence: 99%
“…These combination therapies have been shown to be superior to MTX monotherapy in reducing disease symptoms more rapidly and preventing radiographic damage in more patients . However, some combination therapies may also lead to more adverse reactions than MTX monotherapy . Specific recommendations regarding the MTX dosage when used in combination with other (types of) medication do not exist.…”
Section: Introductionmentioning
confidence: 99%
“…The analysis carried out at our University Hospital provides results that reflect both the Italian trend of the past years [20] and the European one: most reports concern, in fact, antineoplastic and immunomodulating, antimicrobics and the central nervous system drugs (according to the International Classification ATC drug). The antineoplastic and immunomodulatory drugs are most frequently associated with adverse reactions (including an important and frequent reaction, the ineffectiveness) mainly for two reasons: the diseases for which they are prescribed, as they are chronic diseases often associated with different comorbidity, and the fact that these biological drugs belong to the category of medications which represent difficult therapeutic response [21][22][23][24][25].…”
Section: Discussionmentioning
confidence: 99%
“…Both the European League Against Rheumatism 2 and the American College of Rheumatology 3 recommend early treatment with methotrexate for RA. Methotrexate can be described as safe and efficacious, rather than unusual, treatment and has been in use since the mid‐1980s 13 , 14 . The concept of gaining control of inflammatory arthritis as early as possible to prevent joint damage and disability is compelling, and the words “strong” or, preferably, “effective” used in that context can be seen as much more positive and accurate.…”
Section: Methotrexate Mythsmentioning
confidence: 99%